Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 8161
TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235381(US9393245, 113 | BDBM287835)
Affinity DataIC50: 0.300nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235368(US9393245, 98 | US10085990, Example 98)
Affinity DataIC50: 0.300nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235363(US9393245, 93 | US10085990, Example 93)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235364(US9393245, 94 | US10085990, Example 94)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235366(US9393245, 96 | US10085990, Example 96)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235367(US9393245, 97 | US10085990, Example 97)
Affinity DataIC50: 0.600nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235370(US9393245, 100 | US10085990, Example 100)
Affinity DataIC50: 0.900nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235362(US9393245, 91 | US10085990, Example 91)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235375(US9393245, 107 | US10085990, Example 107)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235359(US9393245, 88 | US10085990, Example 88)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235355(US9393245, 83 | US10085990, Example 83)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135819(US8853226, 103 | US9393245, 103 | US10085990, Exam...)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235350(US9393245, 78 | US10085990, Example 78)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235365(US9393245, 95 | US10085990, Example 95)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235361(US9393245, 90 | US10085990, Example 90)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235358(US9393245, 87 | US10085990, Example 87)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235390(US9393245, 126 | US10085990, Example 126)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135817(US8853226, 84 | US9393245, 84 | US10085990, Exampl...)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235383(US9393245, 116 | US10085990, Example 116)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135818(US8853226, 92 | US9393245, 92 | US10085990, Exampl...)
Affinity DataIC50: 2.40nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235374(US9393245, 106 | US10085990, Example 106)
Affinity DataIC50: 4nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235344(US9393245, 72 | US10085990, Example 72)
Affinity DataIC50: 4nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235360(US9393245, 89 | US10085990, Example 89)
Affinity DataIC50: 5nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135824(US8853226, 127 | US9393245, 127 | US10085990, Exam...)
Affinity DataIC50: 6nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235347(US9393245, 75 | US10085990, Example 75)
Affinity DataIC50: 6nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135816(US8853226, 54 | US9393245, 54 | US10085990, Exampl...)
Affinity DataIC50: 6nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235377(US9393245, 109 | US10085990, Example 109)
Affinity DataIC50: 8nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235345(US9393245, 73 | US10085990, Example 73)
Affinity DataIC50: 9nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135819(US8853226, 103 | US9393245, 103 | US10085990, Exam...)
Affinity DataIC50: 17nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235369(US9393245, 99 | US10085990, Example 99)
Affinity DataIC50: 20nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135824(US8853226, 127 | US9393245, 127 | US10085990, Exam...)
Affinity DataIC50: 25nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135822(US8853226, 121 | US9393245, 121 | US10085990, Exam...)
Affinity DataIC50: 26nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135821(US8853226, 118 | US9393245, 118 | US10085990, Exam...)
Affinity DataIC50: 29nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135820(US8853226, 115 | US9393245, 115 | US10085990, Exam...)
Affinity DataIC50: 29nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM135815(US8853226, 51 | US9393245, 51 | US10085990, Exampl...)
Affinity DataIC50: 30nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235382(US9393245, 114 | US10085990, Example 114)
Affinity DataIC50: 31nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135823(US8853226, 122 | US9393245, 122 | US10085990, Exam...)
Affinity DataIC50: 39nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135820(US8853226, 115 | US9393245, 115 | US10085990, Exam...)
Affinity DataIC50: 49nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135819(US8853226, 103 | US9393245, 103 | US10085990, Exam...)
Affinity DataIC50: 55nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135822(US8853226, 121 | US9393245, 121 | US10085990, Exam...)
Affinity DataIC50: 59nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135818(US8853226, 92 | US9393245, 92 | US10085990, Exampl...)
Affinity DataIC50: 68nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135824(US8853226, 127 | US9393245, 127 | US10085990, Exam...)
Affinity DataIC50: 73nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235379(US9393245, 111 | US10085990, Example 111)
Affinity DataIC50: 74nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135816(US8853226, 54 | US9393245, 54 | US10085990, Exampl...)
Affinity DataIC50: 78nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135823(US8853226, 122 | US9393245, 122 | US10085990, Exam...)
Affinity DataIC50: 80nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135821(US8853226, 118 | US9393245, 118 | US10085990, Exam...)
Affinity DataIC50: 80nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM235378(US9393245, 110 | US10085990, Example 110)
Affinity DataIC50: 123nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135815(US8853226, 51 | US9393245, 51 | US10085990, Exampl...)
Affinity DataIC50: 126nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135818(US8853226, 92 | US9393245, 92 | US10085990, Exampl...)
Affinity DataIC50: 151nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandPNGBDBM135820(US8853226, 115 | US9393245, 115 | US10085990, Exam...)
Affinity DataIC50: 163nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: